Viela Bio Reaches Analyst Target Price
March 05, 2020 at 10:11 AM EST
In recent trading, shares of Viela Bio Inc (VIE) have crossed above the average analyst 12-month target price of $46.33, changing hands for $52.88/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..